Human T-Lymphotropic Virus Type 1-Induced CC Chemokine Ligand 22 Maintains a High Frequency of Functional FoxP3+ Regulatory T Cells
- 1 July 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (1) , 183-189
Abstract
We recently reported that human T-lymphotropic virus type 1 (HTLV-1) infection is accompanied by a high frequency of CD4+FoxP3+ cells in the circulation. In asymptomatic carriers of HTLV-1 and in patients with HTLV-1–associated inflammatory and malignant diseases, a high FoxP3+ cell frequency correlated with inefficient cytotoxic T cell-mediated killing of HTLV-1–infected cells. In adult T cell leukemia/lymphoma (ATLL), the FoxP3+ population was distinct from the leukemic T cell clones. However, the cause of the increase in FoxP3+ cell frequency in HTLV-1 infection was unknown. In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1–infected subjects and that the concentration is strongly correlated with the frequency of FoxP3+ cells, which express the CCL22 receptor CCR4. Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3+ cells in vitro. Finally, we show that FoxP3+ cells inhibit the proliferation of ex vivo, autologous leukemic clones from patients with ATLL. We conclude that HTLV-1–induced CCL22 causes the high frequency of FoxP3+ cells observed in HTLV-1 infection; these FoxP3+ cells may both retard the progression of ATLL and HTLV-1–associated inflammatory diseases and contribute to the immune suppression seen in HTLV-1 infection, especially in ATLL.Keywords
This publication has 44 references indexed in Scilit:
- Regulatory T Cell Expansion in HTLV-1 and Strongyloidiasis Co-infection Is Associated with Reduced IL-5 Responses to Strongyloides stercoralis AntigenPLOS Neglected Tropical Diseases, 2009
- The Avidity and Lytic Efficiency of the CTL Response to HTLV-1The Journal of Immunology, 2009
- CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural EffusionClinical Cancer Research, 2009
- High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL responseBlood, 2008
- Regulatory T cells and tumour immunity – observations in mice and menImmunology, 2007
- The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphomaLeukemia, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Infective Dermatitis Associated with the Human T Cell Lymphotropic Virus Type I in Salvador, Bahia, BrazilClinical Infectious Diseases, 2005
- Regulatory T cells under scrutinyNature Reviews Immunology, 2003
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986